Other
Major Abdominal Surgery
0
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Major Abdominal Surgery is an early-stage landscape with 0 programs across 2 companies. The most active players are GSK, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
17
clinical trials
Completed11 · 65%
Recruiting2 · 12%
Not yet recruiting1 · 6%
Unknown status1 · 6%
Withdrawn1 · 6%
Terminated1 · 6%
Clinical Trials
Trial Activity
17 trials
Analgesic Effect of Melatonin and Vitamin C Administration, Alone or In Combination in Major Abdominal Surgery.
Not yet recruiting·—·N/A·NCT06374771·60 enrolled
The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery
Completed·—·Phase 4·NCT02728921·70 enrolled
Evaluation of Plasma Concentrations of Intravenous Lidocaine and Epidural Ropivacaine When Used in Combination in Major Abdominal Surgery
Completed·—·Phase 4·NCT05368753·51 enrolled
Evaluation of the Early Use of Norepinephrine in Major Abdominal Surgery on Postoperative Organ Dysfunction
Completed·—·Phase 3·NCT05276596·500 enrolled
Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery
Completed·—·Phase 4·NCT02361060·130 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)